NR1H4 and obesity disorder: In turn, inhibition of intestinal FXR in obese mice decreases ceramide levels both in the intestine and circulation, which resolves hepatic steatosis and enhances the thermogenic capacity of adipose tissue, in part through increased mitochondrial uncoupling and adipose tissue browning to ameliorate obesity and insulin resistance [219–221].